TME Pharma
Berlin
About TME Pharma
TME Pharma is a biopharmaceutical company, develops biostable aptamers and substances based on mirror image nucleic acids. Its Spiegelmer is a mirror image oligonucleotide therapeutic for the pharmacologically relevant target. The company has a strategic alliance with Pfizer, Inc. NOXXON Pharma AG was founded in 1997 and is based in Berlin, Germany.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $170.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2025)
- Ticker: epa:ALTME
- Website: tmepharma.com
- Phone: 49 30 72 62 47 0
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tme-pharma-72135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.